Aldeyra Therapeutics: 2 insiders bought $135,400 of shares
2 insiders at Aldeyra Therapeutics bought $135,400 of its shares, as reported to the SEC on November 13.
The purchases
2 insiders
Purchase on Nov 11, filed on Nov 13
2
Buyers
$135.4k
Bought
0
Sellers
Director
RD
Richard Douglas
Buy · $128.9k · 200,000 shares
+102.6%
Other executive
MA
Michael Alfieri
Buy · $6.5k · 10,000 shares
+133.3%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.